Navigation Links
Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer
Date:10/14/2008

Despite Widespread Use, Formulary Coverage of Targeted Cancer Therapies is

Inconsistent, According to a New Report from Decision Resources

WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, of the many targeted cancer agents in Phase III clinical trials in the adjuvant setting, surveyed oncologists say that Genentech/Roche/Chugai's Avastin in early-stage colorectal cancer holds the most promise to achieve regulatory approval. Additionally, more than half of surveyed oncologists indicated that the minimum benefit that would persuade them to prescribe Avastin for early-stage colorectal cancer would be an 18 percent improvement in overall survival rates or a 21 percent improvement in disease-free survival rates.

The new Physician & Payer Forum report Targeted Cancer Therapies: The Shift from Metastatic to Early-Stage Disease. Clinician and Payer Attitudes finds that, in addition to Avastin, nearly all surveyed oncologists prescribe Genentech/Roche/Chugai's Herceptin, GlaxoSmithKline's Tykerb, Pfizer's Sutent and Bayer Healthcare/Onyx's Nexavar for their approved indications in cancer, which include breast cancer, non-small-cell lung cancer and renal cell carcinoma. The report finds that, while these agents have survival benefits, formulary coverage by managed care organizations (MCOs) of targeted cancer agents is inconsistent despite regulatory prescription drug plan guidelines that call for coverage of virtually all anti-tumor agents.

According to the report, MCO pharmacy directors commonly cite insufficient clinical benefit over cheaper alternatives as the reason for lack of reimbursement for targeted cancer therapies. Evidence has demonstrated that patients who have failed Herceptin in the metastatic setting should switch to Tykerb, and, according to National Cancer Institute guidelines, patients who fail Sutent could
'/>"/>

SOURCE Decision Resources
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. News Media Advisory: Worlds Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments
2. Vermillion Receives Award From the Society of Gynecologic Oncologists
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
5. Amylin Pharmaceuticals to Present Novel Data on Promising Obesity Pipeline at 2008 Annual Scientific Meeting of The Obesity Society
6. ThromboGenics Announces Promising Results of MITI IV Phase II Trial in the Treatment of Acute Stroke with Microplasmin
7. Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy
8. Symposium Highlights Yale Study Indicating Role of AHCC(R) for Immune System Enhancement and as a Promising Cancer Preventative
9. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
10. Michael J. Fox Foundation Awards $2.4 Million for Validation of Nine Promising Therapeutic Targets for Parkinsons Disease
11. HUYA Bioscience Intl Announces Pre-IND Outcome for HBI-3000 - Promising Anti-Arrhythmia Compound Sourced From China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Pete Rose, baseball,s all-time hits ... and arthritis pain reliever Myoflex, Ducere Pharma has announced. ... we are excited to have him on board with Myoflex," ... "He is a legendary player who is known across all ...
(Date:1/23/2015)... 23, 2015  iMD Companies, Inc. (ICBU) has repositioned itself as ... and grab a foothold in the hydroponic, hemp and medical ... a presence in the sector, and recently partnering with the ... hemp and medical marijuana, iMD is committing to bring its ...
(Date:1/23/2015)... Jan. 23, 2015   Leatt Corporation  (OTCQB: LEAT), a ... for all forms of sports, including extreme motor sports, ... announced today that the UISP Lega Motociclismo Lombardia, an ... riders to wear a neck brace during its racing ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3
... Where: Laemmle,s Town Center 5, 17200 Ventura Blvd., Encino ... p.m. VIP and remarks following at 4 p.m. Pioneering ... What: Premiere screening of "CODY," the inspiring story of ... Narrated by Glenn Close, the film tells the story of ...
... April 16 Trubion Pharmaceuticals, Inc. (Nasdaq: ... present data regarding its SCORPION(TM) multispecific therapeutic technology ... Association of Cancer Research (AACR) in Denver, April ... present data demonstrating the selectivity and high potency ...
Cached Medicine Technology:University of Redlands Student Cody Unser Documentary Run to Start Today in L.A. 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 2Trubion Pharmaceuticals, Inc. Announces Upcoming Presentation at the 2009 American Association of Cancer Research Annual Meeting 3
(Date:1/22/2015)... A new white paper by The Beryl ... the long-term care environment as well as provides recommendations ... paper, “The Power of Person-Centeredness in Long-Term Care: A ... the patient, resident and family experience in long-term care ...
(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
Breaking Medicine News(10 mins):Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... macular degeneration (AMD)including an intravitreous (into the eye) injection ... compound approved for use against the eye diseasedo not ... cardiovascular complications or death when compared with existing therapies, ... Archives of Ophthalmology , one of the JAMA/Archives ...
... By Jenifer Goodwin HealthDay Reporter , MONDAY, ... your dog home alone without having to worry about chewed ... how to look at the sunny side of life. ... more likely to become distressed and anxious when left alone ...
... , SUNDAY, Oct. 10 (HealthDay News) -- Scientists have found ... for obesity. The findings are reported in two new ... Nature Genetics . , In one report, researchers say they ... the involvement of 14 others. In a second report, the ...
... 2010 A clinical trial at UT Southwestern Medical ... to standard insulin therapy might help rein in the ... diabetes. This is the first type 1 diabetes ... fat cells and involved in body-weight regulation. For this ...
... and structured weight loss programs, can result in significant weight ... two reports that were posted online today by JAMA ... early online to coincide with the presentation of these papers ... The articles will appear in the October 27 print ...
... at UT Southwestern Medical Center have created an experimental ... in the brain and is believed to contribute to ... similar so-called DNA vaccines that the UT Southwestern researchers ... stimulated more than 10 times as many antibodies that ...
Cached Medicine News:Health News:Certain new therapies for age-related eye disease do not appear to increase heart risks 2Health News:Pessimistic Pooches May Be Prone to Separation Anxiety 2Health News:Pessimistic Pooches May Be Prone to Separation Anxiety 3Health News:Researchers Pinpoint Array of Obesity Genes 2Health News:Researchers Pinpoint Array of Obesity Genes 3Health News:UT Southwestern study to determine whether leptin helps type 1 diabetes patients 2Health News:UT Southwestern study to determine whether leptin helps type 1 diabetes patients 3Health News:Clinical trials demonstrate effective weight loss strategies for obese and overweight adults 2Health News:Clinical trials demonstrate effective weight loss strategies for obese and overweight adults 3Health News:UT Southwestern researchers create experimental vaccine against Alzheimer's 2
... frames ensure cleanroom compatibility ... and chemical resistance. These ... user-friendly pnuematic controls for ... footring standard. Five leg ...
... The ideal modular cleanroom for biological ... that require cleanliness (to Class 10/ISO ... precision-joined to create ultra-smooth surfaces that ... disinfect. One-inch radius corners simplify cleaning. ...
Inquire...
Inquire...
Medicine Products: